Imagindairy Accelerates Bovine-Free Dairy Revolution with Industrial-Scale Production Facility
Source: The DairyNews
Israeli food tech start-up, Imagindairy, is making waves in the dairy industry by acquiring precision fermentation production lines at an industrial-scale facility. Pioneering the creation of authentic dairy proteins without cows, the company's advanced technology, driven by a proprietary AI platform, positions it to offer animal-free products at cost parity with traditional dairy.
Dr. Eyal Afergan, Imagindairy's co-founder and CEO, emphasizes the significance of overcoming historical challenges in achieving cost parity within the precision fermentation sector. The start-up, confident in its capabilities, is already producing industrial-scale batches at a competitive cost structure to traditional dairy.
The new facility grants Imagindairy access to over 100,000 liters of fermentation capacity, with plans to triple this volume in the next one to two years. Dr. Afergan envisions a future supermarket aisle filled with sustainably-made products, including milk, cheese, yogurt, and ice cream crafted with precision fermented ingredients, catering to conscious consumers.
As competition in the precision fermentation dairy market rises, Imagindairy's decision to fully own and operate production marks a significant step forward. Dr. Afergan notes the start-up's progress ahead of its ambitious commercial production scaleup schedule, anticipating a surge in demand for precision fermentation dairy products.
In a parallel development, Imagindairy received a "no questions" response from the US Food & Drug Administration, affirming the Generally Recognized as Safe (GRAS) status for its animal-free dairy protein. This regulatory green light paves the way for collaborations with food and beverage manufacturers.
Shmuel Chafets, founder and partner at Target Global, expresses confidence in Imagindairy's disruptive potential in the dairy industry. The company's achievements, combined with its culture of capital efficiency, position it as a force in shaping the future of dairy.
Imagindairy's animal-free dairy protein products are slated for launch in the US within the coming year, marking a significant stride toward reshaping the dairy landscape.
The new facility grants Imagindairy access to over 100,000 liters of fermentation capacity, with plans to triple this volume in the next one to two years. Dr. Afergan envisions a future supermarket aisle filled with sustainably-made products, including milk, cheese, yogurt, and ice cream crafted with precision fermented ingredients, catering to conscious consumers.
As competition in the precision fermentation dairy market rises, Imagindairy's decision to fully own and operate production marks a significant step forward. Dr. Afergan notes the start-up's progress ahead of its ambitious commercial production scaleup schedule, anticipating a surge in demand for precision fermentation dairy products.
In a parallel development, Imagindairy received a "no questions" response from the US Food & Drug Administration, affirming the Generally Recognized as Safe (GRAS) status for its animal-free dairy protein. This regulatory green light paves the way for collaborations with food and beverage manufacturers.
Shmuel Chafets, founder and partner at Target Global, expresses confidence in Imagindairy's disruptive potential in the dairy industry. The company's achievements, combined with its culture of capital efficiency, position it as a force in shaping the future of dairy.
Imagindairy's animal-free dairy protein products are slated for launch in the US within the coming year, marking a significant stride toward reshaping the dairy landscape.
